Mon, August 28, 2023

Eliana Merle Initiated (AKRO) at Strong Buy and Held Target at $83 on, Aug 28th, 2023

Eliana Merle of UBS, Initiated "Akero Therapeutics, Inc." (AKRO) at Strong Buy and Held Target at $83 on, Aug 28th, 2023.

Eliana has made no other calls on AKRO in the last 4 months.



There are 3 other peers that have a rating on AKRO. Out of the 3 peers that are also analyzing AKRO, 0 agree with Eliana's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Eliana


  • Michael Ulz of "Morgan Stanley" Maintained at Buy with Increased Target to $70 on, Monday, June 12th, 2023
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $64 on, Wednesday, June 7th, 2023
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, May 17th, 2023